Article
Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
1 Apr 2022
Abstract excerpt
Despite the introduction of immune checkpoint inhibitors and antibody–drug conjugates to the management of advanced urothelial carcinoma, the disease is generally incurable. The increasing incorporation of next-generation sequencing of tumor tissue into the characterization of bladder cancer has led to a better understanding of the somatic genetic aberrations potentially involved in its pathogenesis. Genetic...
Topics
Join the communities discussing this publication.